Evidence map›Paper›PMID 28651013›Full record

ArticlePloS one2017

Loss of prion protein induces a primed state of type I interferon-responsive genes.

Giulia Malachin, Malin R Reiten, Øyvind Salvesen, Håvard Aanes, Jorke H Kamstra, Kerstin Skovgaard, Peter M H Heegaard, Cecilie Ersdal, Arild Espenes, Michael A Tranulis and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Giulia MalachinFaculty of Veterinary Medicine, Norwegian University of Life Sciences, Oslo, Norway.
Malin R ReitenFaculty of Veterinary Medicine, Norwegian University of Life Sciences, Oslo, Norway.
Øyvind SalvesenFaculty of Veterinary Medicine, Norwegian University of Life Sciences, Oslo, Norway.ORCID http://orcid.org/0000-0003-2480-1294
Håvard AanesDepartment of Microbiology, Division of diagnostics and intervention, Institute of Clinical Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Jorke H KamstraFaculty of Veterinary Medicine, Norwegian University of Life Sciences, Oslo, Norway.ORCID http://orcid.org/0000-0001-7984-0229
Kerstin SkovgaardInnate Immunology Group, Section for Immunology and Vaccinology, National Veterinary Institute, Technical University of Denmark, Kgs. Lyngby, Denmark.ORCID http://orcid.org/0000-0001-5663-4879
Peter M H HeegaardInnate Immunology Group, Section for Immunology and Vaccinology, National Veterinary Institute, Technical University of Denmark, Kgs. Lyngby, Denmark.
Cecilie ErsdalFaculty of Veterinary Medicine, Norwegian University of Life Sciences, Oslo, Norway.
Arild EspenesFaculty of Veterinary Medicine, Norwegian University of Life Sciences, Oslo, Norway.
Michael A TranulisFaculty of Veterinary Medicine, Norwegian University of Life Sciences, Oslo, Norway.ORCID http://orcid.org/0000-0002-9222-8509
Maren K BakkebøFaculty of Veterinary Medicine, Norwegian University of Life Sciences, Oslo, Norway.ORCID http://orcid.org/0000-0002-2871-9813
Norwegian University of Life Sciences · NOTechnical University of Denmark · DKOslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cellular prion protein (PrPC) has been extensively studied because of its pivotal role in prion diseases; however, its functions remain incompletely understood. A unique line of goats has been identified that carries a nonsense mutation that abolishes synthesis of PrPC. In these animals, the PrP-encoding mRNA is rapidly degraded. Goats without PrPC are valuable in re-addressing loss-of-function phenotypes observed in Prnp knockout mice. As PrPC has been ascribed various roles in immune cells, we analyzed transcriptomic responses to loss of PrPC in peripheral blood mononuclear cells (PBMCs) from normal goat kids (n = 8, PRNP+/+) and goat kids without PrPC (n = 8, PRNPTer/Ter) by mRNA sequencing. PBMCs normally express moderate levels of PrPC. The vast majority of genes were similarly expressed in the two groups. However, a curated list of 86 differentially expressed genes delineated the two genotypes. About 70% of these were classified as interferon-responsive genes. In goats without PrPC, the majority of type I interferon-responsive genes were in a primed, modestly upregulated state, with fold changes ranging from 1.4 to 3.7. Among these were ISG15, DDX58 (RIG-1), MX1, MX2, OAS1, OAS2 and DRAM1, all of which have important roles in pathogen defense, cell proliferation, apoptosis, immunomodulation and DNA damage response. Our data suggest that PrPC contributes to the fine-tuning of resting state PBMCs expression level of type I interferon-responsive genes. The molecular mechanism by which this is achieved will be an important topic for further research into PrPC physiology.

Indexed as

AnimalsCell LineFemaleGene ExpressionGene Expression ProfilingGene Knockout TechniquesGoatsHomeodomain ProteinsHumansInterferon Type ILeukocytesMaleMicePrPC ProteinsHomeodomain ProteinsInterferon Type IMSX2 proteinPrPC Proteins

Identifiers

PMID28651013
PMCPMC5484497
OpenAlexW2668757385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.